Sagimet Biosciences Series Stock Market Value
| SGMT Stock | 5.96 0.10 1.65% |
| Symbol | Sagimet |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sagimet Biosciences. If investors know Sagimet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sagimet Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sagimet Biosciences is measured differently than its book value, which is the value of Sagimet that is recorded on the company's balance sheet. Investors also form their own opinion of Sagimet Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Sagimet Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sagimet Biosciences' market value can be influenced by many factors that don't directly affect Sagimet Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sagimet Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sagimet Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sagimet Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sagimet Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sagimet Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sagimet Biosciences.
| 11/27/2025 |
| 12/27/2025 |
If you would invest 0.00 in Sagimet Biosciences on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Sagimet Biosciences Series or generate 0.0% return on investment in Sagimet Biosciences over 30 days. Sagimet Biosciences is related to or competes with Arcturus Therapeutics, Humacyte, Assembly Biosciences, Zura Bio, Voyager Therapeutics, Entrada Therapeutics, and Foghorn Therapeutics. More
Sagimet Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sagimet Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sagimet Biosciences Series upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 36.94 | |||
| Value At Risk | (8.25) | |||
| Potential Upside | 6.39 |
Sagimet Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sagimet Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sagimet Biosciences' standard deviation. In reality, there are many statistical measures that can use Sagimet Biosciences historical prices to predict the future Sagimet Biosciences' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | (0.03) |
Sagimet Biosciences Backtested Returns
Sagimet Biosciences owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0147, which indicates the firm had a -0.0147 % return per unit of risk over the last 3 months. Sagimet Biosciences Series exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sagimet Biosciences' insignificant Risk Adjusted Performance, coefficient of variation of (6,796), and Variance of 32.52 to confirm the risk estimate we provide. The entity has a beta of 2.95, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sagimet Biosciences will likely underperform. At this point, Sagimet Biosciences has a negative expected return of -0.0839%. Please make sure to validate Sagimet Biosciences' standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Sagimet Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.31 |
Below average predictability
Sagimet Biosciences Series has below average predictability. Overlapping area represents the amount of predictability between Sagimet Biosciences time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sagimet Biosciences price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Sagimet Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Sagimet Biosciences lagged returns against current returns
Autocorrelation, which is Sagimet Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sagimet Biosciences' stock expected returns. We can calculate the autocorrelation of Sagimet Biosciences returns to help us make a trade decision. For example, suppose you find that Sagimet Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sagimet Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sagimet Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sagimet Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sagimet Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Sagimet Biosciences Lagged Returns
When evaluating Sagimet Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sagimet Biosciences stock have on its future price. Sagimet Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sagimet Biosciences autocorrelation shows the relationship between Sagimet Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Sagimet Biosciences Series.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sagimet Stock Analysis
When running Sagimet Biosciences' price analysis, check to measure Sagimet Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sagimet Biosciences is operating at the current time. Most of Sagimet Biosciences' value examination focuses on studying past and present price action to predict the probability of Sagimet Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sagimet Biosciences' price. Additionally, you may evaluate how the addition of Sagimet Biosciences to your portfolios can decrease your overall portfolio volatility.